Issue of Equity

Eco Animal Health Group plc ("Eco" or the "Company")


                   ISSUE OF EQUITY


The Company announces that on 19 May 2009, 230,762 new ordinary shares of 5p
each were issued to shareholders who elected to receive new shares instead of
cash for the interim dividend in respect of the year ended 31 March 2009 and who
held Ordinary shares on the record date of 17 April 2009.  The new shares are
expected to be admitted to trading on 26 May 2009.

Following this scrip dividend, the Company has 46,633,169 ordinary shares in
issue and the following directors' shareholdings have increased.

               Number of      Shareholding    Percent
               shares held    post scrip      shareholding
               prior to                       post scrip
               scrip
Peter          10,500,004     10,555,000      22.63%
Lawrence &
family
Executive
Chairman
Kevin          7,776          7,819           0.02%
Stockdale
Finance
Director


Enquires:

Eco Animal Health Group plc
Peter Lawrence, Executive Chairman                   020 8336 6190

Cenkos Securities plc
Liz Bowman                                           020 7397 8926
(Nominated Adviser)


ECO Animal Health Group plc is a leader in the development, registration and
marketing of pharmaceutical products. Our products for these global growth
markets promote well-being in animals. Our financial goals are achieved through
the careful and responsible application of science to generate value for our
shareholders.